UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Regulation of fatty acid synthase on tumor and progress in the development of related therapies

Chinese medical journal, 2024-08, Vol.137 (16), p.1894-1902

2024

Volltextzugriff (PDF)

Sintilimab Plus Platinum and Gemcitabine as First-Line Treatment for Advanced or Metastatic Squamous NSCLC: Results From a Randomized, Double-Blind, Phase 3 Trial (ORIENT-12)

Journal of thoracic oncology, 2021-09, Vol.16 (9), p.1501-1511

2021

Volltextzugriff (PDF)

Epidermal growth factor receptor compound and concomitant mutations: advances in precision treatment strategies

Chinese medical journal, 2023-12, Vol.136 (23), p.2776-2786

2023

Volltextzugriff (PDF)

Molecular classification of small cell lung cancer subtypes: Characteristics, prognostic factors, and clinical translation

Chinese medical journal, 2024-01, Vol.137 (2), p.130-139

2024

Volltextzugriff (PDF)

Therapeutic exploration of uncommon EGFR exon 20 insertion mutations in advanced non-small cell lung cancer: breaking through brambles and thorns

Journal of cancer research and clinical oncology, 2022, Vol.148 (1), p.163-176

2022

Volltextzugriff (PDF)

Value of neutrophil-to-lymphocyte ratio for predicting lung cancer prognosis: A meta-analysis of 7,219 patients

Molecular and clinical oncology, 2017-09, Vol.7 (3), p.498-506

2017

Volltextzugriff (PDF)

Apatinib Plus Gefitinib as First-Line Treatment in Advanced EGFR-Mutant NSCLC: The Phase III ACTIVE Study (CTONG1706)

Journal of thoracic oncology, 2021-09, Vol.16 (9), p.1533-1546

2021

Volltextzugriff (PDF)

Precision targeted therapy for EGFR mutation‐positive NSCLC: Dilemmas and coping strategies

Thoracic cancer, 2023-05, Vol.14 (13), p.1121-1134

2023

Volltextzugriff (PDF)

Combination of radiofrequency ablation and sequential cellular immunotherapy improves progression‐free survival for patients with hepatocellular carcinoma

International journal of cancer, 2014-01, Vol.134 (2), p.342-351

2014

Volltextzugriff (PDF)

An intragenic long noncoding RNA interacts epigenetically with the RUNX1 promoter and enhancer chromatin DNA in hematopoietic malignancies

International journal of cancer, 2014-12, Vol.135 (12), p.2783-2794

2014

Volltextzugriff (PDF)

Advances and challenges in immunotherapy of small cell lung cancer

Chinese journal of cancer research, 2020-02, Vol.32 (1), p.115-128

2020

Volltextzugriff (PDF)

Long noncoding RNA-mediated intrachromosomal interactions promote imprinting at the Kcnq1 locus

The Journal of cell biology, 2014-01, Vol.204 (1), p.61-75

2014

Volltextzugriff (PDF)

Glioma stem-like cells evade interferon suppression through MBD3/NuRD complex-mediated STAT1 downregulation

The Journal of experimental medicine, 2020-05, Vol.217 (5)

2020

Volltextzugriff (PDF)

Nutritional features-based clustering analysis as a feasible approach for early identification of malnutrition in patients with cancer

European journal of clinical nutrition, 2021-08, Vol.75 (8), p.1291-1301

2021

Volltextzugriff (PDF)

Clinical challenges in neoadjuvant immunotherapy for non-small cell lung cancer

Chinese journal of cancer research, 2021-04, Vol.33 (2), p.203-215

2021

Volltextzugriff (PDF)

Phase 1 dose escalation study of FGFR4 inhibitor in combination with pembrolizumab in advanced solid tumors patients

Cancer medicine (Malden, MA), 2023-04, Vol.12 (7), p.7762-7771

2023

Volltextzugriff (PDF)

Anti-angiogenesis: Opening a new window for immunotherapy

Life sciences (1973), 2020-10, Vol.258, p.118163-118163, Article 118163

2020

Volltextzugriff (PDF)

Challenges of evaluating immunotherapy efficacy in solid tumors

Chinese journal of cancer research, 2019-12, Vol.31 (6), p.853-861

2019

Volltextzugriff (PDF)

Several anthropometric measurements and cancer mortality: predictor screening, threshold determination, and joint analysis in a multicenter cohort of 12138 adults

European journal of clinical nutrition, 2022-05, Vol.76 (5), p.756-764

2022

Volltextzugriff (PDF)

Advances in novel molecular typing and precise treatment strategies for small cell lung cancer

Chinese journal of cancer research, 2021-08, Vol.33 (4), p.522-534

2021

Volltextzugriff (PDF)

Coexisting opportunities and challenges: In which scenarios can minimal/measurable residual disease play a role in advanced non-small cell lung cancer?

Chinese journal of cancer research, 2021-10, Vol.33 (5), p.574-582

2021

Volltextzugriff (PDF)

Epigenetic reprogramming reverses the malignant epigenotype of the MMP/TIMP axis genes in tumor cells

International journal of cancer, 2014-04, Vol.134 (7), p.1583-1594

2014

Volltextzugriff (PDF)

CAR-T in solid tumors: Blazing a new trail through the brambles

Life sciences (1973), 2020-11, Vol.260, p.118300-11, Article 118300

2020

Volltextzugriff (PDF)

Validating the pivotal role of the immune system in low‐dose radiation‐induced tumor inhibition in Lewis lung cancer‐bearing mice

Cancer medicine (Malden, MA), 2018-04, Vol.7 (4), p.1338-1348

2018

Volltextzugriff (PDF)

Present and future of cancer immunotherapy: A tumor microenvironmental perspective

Oncology letters, 2018-10, Vol.16 (4), p.4105-4113

2018

Volltextzugriff (PDF)

1 – 25 von 146

Suche als RSS-Feed

Aktive Filter

SpracheChinesisch

KollektionJournals@Ovid Ovid Full Text

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(140)
Mit Volltextzugriff
(129)

Publikationsform

Artikel
(146)

Sprache

Englisch
(146)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Regulation of fatty acid synthase on tumor and progress in the development of related therapies

Sintilimab Plus Platinum and Gemcitabine as First-Line Treatment for Advanced or Metastatic Squamous NSCLC: Results From a Randomized, Double-Blind, Phase 3 Trial (ORIENT-12)

Epidermal growth factor receptor compound and concomitant mutations: advances in precision treatment strategies

Molecular classification of small cell lung cancer subtypes: Characteristics, prognostic factors, and clinical translation

Therapeutic exploration of uncommon EGFR exon 20 insertion mutations in advanced non-small cell lung cancer: breaking through brambles and thorns

Value of neutrophil-to-lymphocyte ratio for predicting lung cancer prognosis: A meta-analysis of 7,219 patients

Apatinib Plus Gefitinib as First-Line Treatment in Advanced EGFR-Mutant NSCLC: The Phase III ACTIVE Study (CTONG1706)

Precision targeted therapy for EGFR mutation‐positive NSCLC: Dilemmas and coping strategies

Combination of radiofrequency ablation and sequential cellular immunotherapy improves progression‐free survival for patients with hepatocellular carcinoma

An intragenic long noncoding RNA interacts epigenetically with the RUNX1 promoter and enhancer chromatin DNA in hematopoietic malignancies

Advances and challenges in immunotherapy of small cell lung cancer

Long noncoding RNA-mediated intrachromosomal interactions promote imprinting at the Kcnq1 locus

Glioma stem-like cells evade interferon suppression through MBD3/NuRD complex-mediated STAT1 downregulation

Nutritional features-based clustering analysis as a feasible approach for early identification of malnutrition in patients with cancer

Clinical challenges in neoadjuvant immunotherapy for non-small cell lung cancer

Phase 1 dose escalation study of FGFR4 inhibitor in combination with pembrolizumab in advanced solid tumors patients

Anti-angiogenesis: Opening a new window for immunotherapy

Challenges of evaluating immunotherapy efficacy in solid tumors

Several anthropometric measurements and cancer mortality: predictor screening, threshold determination, and joint analysis in a multicenter cohort of 12138 adults

Advances in novel molecular typing and precise treatment strategies for small cell lung cancer

Coexisting opportunities and challenges: In which scenarios can minimal/measurable residual disease play a role in advanced non-small cell lung cancer?

Epigenetic reprogramming reverses the malignant epigenotype of the MMP/TIMP axis genes in tumor cells

CAR-T in solid tumors: Blazing a new trail through the brambles

Validating the pivotal role of the immune system in low‐dose radiation‐induced tumor inhibition in Lewis lung cancer‐bearing mice

Present and future of cancer immunotherapy: A tumor microenvironmental perspective

Aktive Filter

Suchergebnisse filtern